StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)

Close on Nov 18, 2026Market cap $5.36MP/E –Yield –

Cerenome gross margin

Gross margin is gross profit as a percentage of revenue.

Cerenome's gross margin for the twelve months ending Mar 31, 2018 was 15.0%. For fiscal 2018 it was 68.7%, against 5.4% the year before. The highest annual figure on record is 68.7% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 201868.7%+63.3
FY2017Dec 31, 20175.4%−36.3
FY2016Dec 31, 201641.7%+7.5
FY2015Dec 31, 201534.1%−6.5
FY2014Dec 31, 201440.6%−11.3
FY2013Dec 31, 201352.0%−2.1
FY2012Dec 31, 201254.1%+2.1
FY2011Dec 31, 201151.9%−0.7
FY2010Dec 31, 201052.7%+10.8
FY2009Dec 31, 200941.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 201820.8%+41.9
Q4 FY2017Dec 31, 20174.4%−31.2
Q3 FY2017Sep 30, 2017-4.3%−19.7
Q2 FY2017Jun 30, 201727.0%−21.0
Q1 FY2017Mar 31, 2017-21.2%–
Q4 FY2016Dec 31, 201635.5%–
Q3 FY2016Sep 30, 201615.5%–
Q2 FY2016Jun 30, 201648.0%–

More Cerenome figures

See a number that looks wrong?